Repligen Corp (RGEN) Tops Q1 EPS by 3c; Boosts FY14 Revs Outlook

Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.9 million.

Repligen Corp sees FY2014 revenue of $59 - $62 million, versus prior guidance of $58 - $61 million and the consensus of $59 million.

For earnings history and earnings-related data on Repligen Corp (RGEN) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating